.jpg)
In a report released today, Stan Zlotsky from Morgan Stanley maintained a Buy rating on Veeva Systems (NYSE: VEEV), with a price target of $78. The company’s shares closed yesterday at $77.17, close to its 52-week high of $79.15.
Zlotsky has an average return of 51.9% when recommending Veeva Systems.
According to TipRanks.com, Zlotsky is ranked #764 out of 4810 analysts.
Currently, the analyst consensus on Veeva Systems is Moderate Buy and the average price target is $82.40, representing a 6.8% upside.
In a report released yesterday, KeyBanc also assigned a Buy rating to the stock.
See today’s analyst top recommended stocks >>
Veeva Systems’ market cap is currently $10.96B and has a P/E ratio of 82.98. The company has a Price to Book ratio of 12.58.
Based on the recent corporate insider activity of 116 insiders, corporate insider sentiment is neutral on the stock. Most recently, in March 2018, Eleni Nitsa Zuppas, the CMO of VEEV sold 49,793 shares for a total of $3,848,071.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Veeva Systems, Inc. engages in the provision of industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm’s customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company’s customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.
